Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel

Publicado en línea: 27 nov 2015

Páginas: 402 - 408

Recibido: 05 may 2015

Aceptado: 19 jul 2015

DOI: https://doi.org/10.1515/raon-2015-0038

Palabras clave

metastatic castration-resistant prostate cancer, comorbidity, chemotherapy

© 2015 Andrej Zist et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.